Agence de santé publique du Canada / Public Health Agency of Canada
Sauter toute navigation -touch directe z Sauter au menu vertical -touch directe x Sauter au menu principal -touch directe m Sauter toute navigation -touch directe z
English Contactez-nous Aide Recherche Site du Canada
Accueil - ASPC Centres Publications Lignes directrices Index A-Z
Santé - enfants Santé - adultes Santé - aînés Surveillance Santé Canada

 

   Office de la santé publique du Canada

Programmes organisés de dépistage du cancer du sein au Canada - Rapport de 1999 et 2000

RÉFÉRENCES

  1. Société canadienne du cancer. Statistiques canadiennes sur le cancer 2002. Toronto, Canada, 2002.

  2. Santé Canada. Programmes organisés de dépistage du cancer du sein au Canada, Rapport de 1997 et 1998. Ottawa : Ministre de Travaux publics et Services gouvernementaux Canada, 2001.

  3. Santé Canada. Le fardeau économique de la maladie au Canada, 1998. Ottawa : Ministre de Travaux publics et Services gouvernementaux Canada, 2002 Cat. No. H21-136/1998F.

  4. Kelsey JL et Bernstein L. Epidemiology and prevention of breast cancer. Annu Rev Public Health 1996;17:47-67.

  5. Santé Canada. Rapport sommaire : Examen des facteurs de risque de cancer du sein liés au style de vie et à l'environnement. Ottawa : Ministre de Travaux publics et Services gouvernementaux Canada, 2001. Cat. No. H39-586/2001F.

  6. Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster VL. Efficacy of screening mammography. A meta-analysis. JAMA 1995;273:149-54.

  7. WHO: International Agency for Research on Cancer, Handbook for Cancer Prevention Vol. 7, Breast Cancer Screening. IARC Press, 2002.

  8. The Workshop Group. Reducing deaths from breast cancer in Canada. Can Med Assoc J 1989; 141:199-201.

  9. Preventive health care, 2001 update: Should women be routinely taught breast self-examination to screen for breast cancer? Préparé par N. Baxter, MD, PhD, FRCS (C), with the Canadian Task Force on Preventive Health Care, octobre 2000.

  10. Horne T, Groupe de travail sur les indicateurs d'évaluation. Proposed indicators for performance and quality of breast screening programs in Canada. Ottawa : Santé Canada, avril 2000.

  11. Santé Canada. Rapport du Groupe de travail sur les indicateurs d'évaluation : Lignes directrices pour la surveillance de la performance des programmes de dépistage du cancer du sein. Ottawa : Ministre de Travaux publics et Services gouvernementaux Canada, 2002.

  12. Simces Z. Community Development Pilot Projects: BC Cancer Agency Care and Research, 2002.

  13. Faux AM, Lawrence GM, Wheaton ME, Wallis MG, Jeffery CL, Griffiths RK. Slippage in the NHS breast screening programme: an assessment of whether a three year screening round is being achieved. J Med Screen 1998;5:88-91.

  14. Bancej C, Decker K, Chiarelli A, Harrison M, Turner D, Brisson J. Contribution of Clinical Breast Examination to Mammography Screening in the Early Detection of Breast Cancer. Journal of Medical Screening (sous presse).

  15. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. The palpable breast lump: information and recommendations to assist decision-making when a breast lump is detected. Can Med Assoc J 1998;158 (Suppl 3):S3-S8.

  16. Olivotto IA, Mates D, Kan L, Fung J, Samant R, Warren Burhenne LJ. Prognosis, treatment, and recurrence of breast cancer for women attending or not attending the Screening Mammography Program of British Columbia. Breast Cancer Research and Treatment 1999;54:73-81.

  17. Woodman CB, Threlfall AG, Boggis CR, Prior P. Is the three year breast screening interval too long? Occurrence of interval cancers in NHS breast screening programme's north western region. Brit Med J 1995;310:224-26.

  18. Decker KM, Harrison M, Chateau D. Influence of direct referrals on time to diagnosis after an abnormal breast screening result. 2003 (manuscrit non publié).

  19. Olivotto IA; Borugian MJ, Kan L, Harris SR, Rousseau EJ, Thorne SE, Vestrup JA, Wright CJ, Coldman AJ, Hislop TG. Improving the time to diagnosis after an abnormal screening mammogram. Can J Public Health. 2001 Sep-2001 Oct 31; 92(5):366-71.

  20. Rickard MT, Taylor RJ, Fazli MA, El Hassan N. Interval breast cancers in an Australian mammographic screening program. Med J Aust 1998;169:184-87.

  21. Cockburn J, Schofield P, White V, Hill D, Russel I. Predictors of returning for second round screening at a population based mammographic screening programme in Melbourne, Australia. Journal of Epidemiology and Community Health 1997;51(1):62-66.

  22. Lerman C, Rimer B, Trock B, Balshem A, Engstrom PF. Factors associated with repeat adherence to breast screening. Preventive Medicine 1990;19(3):279-90.

  23. Orton M, Fitzpatrick R, Fuller A, Mant D, Mlynek C, Thorogood M. Factors affecting women's response to an invitation to attend for a second breast cancer screening examination. Br J Gen Pract 1991;41:321-3.

  24. Weinberg AD, Lane M, Cooper HP, Kripalani S. Screening behaviours and long-term compliance with mammography guidelines in a breast cancer screening program. American Journal of Preventive Medicine 1997;13(1):29-35.

  25. Bastani R, Kaplan CP, Maxwell AE, Nisenbaum R, Pearce J, Marcus AC. Initial and repeat mammgoraphy screening in a low income multi-ethnic population in Los Angeles. Cancer Epidemiol Biomarkers Prev 1995;4:161-7.

  26. Benedict S, Williams RD, Baron PL. The effect of benign breast biopsy on subsequent breast cancer detection practices. Oncol Nurs Forum 1994;21(9):1467-75.

  27. Pisano ED, Earp J, Schell M, Vokaty K, Denham A. Screening behavior of women after a false-positive mammogram. Radiology 1998;208(1):245-9.

  28. Cockburn J, Schofield P, White V, Hill D, Russel I. Predictors of returning for second round screening at a population based dépistage mammographique programme in Melbourne, Australia. Journal of Epidemiology and Community Health 1997;51(1):62-66.

  29. Gram IT, Lund E, Slenker SE. Quality of life following a false positive mammogram. Br J Cancer 1990;62:1018-1022.

  30. Lerman C, Trock B, Rimer BK et coll. Psychological and behavioral implications of abnormal mammograms. Ann Intern Med 1991;114:657-61.

  31. Marshall G. A comparative study of re-attenders and non-re-attenders for second triennial National Breast Screening Program appointments. Journal of Public Health Medicine 1994; 16(1): 79-86.

  32. Meldrum P, Turnbull D, Dobson HM, Colquhoun C, Harper Gilmour W, McIlwaine GM. Tailored written invitations for second round breast cancer screening: A randomised controlled trial. J Med Screen 1994;1:245-8.

  33. Scaf-Klomp W, van Sonderen FLP, Stewart R, van Dijck JAAM, van den Heuvel WJA. Compliance after 17 years of breast cancer screening. Journal of Medical Screening 1995;2:195-9.

  34. Johnson MM, Hislop TG, Kan L, Coldman AJ, Lai A. Compliance with the screening mammography program of Bristish Columbia: will she return? Can J Public Health 1996;87:176-9.

  35. Chiarelli A, Moravan V, Halapy E, Majpruz V, Mai V, Tatla RK. False positive result and reattendance in the Ontario Breast Screening Program. Journal of Medical Screening (sous presse).

 

[Précédente] [Table des matières] [Prochaine]
Dernière mise à jour : 2003-09-02 début
Avis importants